Country music legend Alan Jackson has announced his farewell tour, titled “Last Call: One More for the Road,” promising fans the best performances despite his ongoing battle with Charcot-Marie-Tooth (CMT) disease. The Grammy-winning musician, who went public with his diagnosis in 2021, is determined to give his all on stage.
“There’s no cure for it, but it’s been affecting me for years. And it’s getting more and more obvious,” Jackson shared with media outlets, shedding light on his struggle with the genetic neurological condition. He was diagnosed with CMT about a decade ago, a condition he inherited from his father.
Charcot-Marie-Tooth disease is a genetic disorder that damages the peripheral nerves, which connect the spine and brain to the limbs. This nerve damage can lead to muscle shrinkage and weakness, particularly in the ankles and feet, and, in some cases, the hands. According to the Mayo Clinic, CMT affects about 1 in every 2,500 people in the U.S., making it one of the most common inherited neurological conditions.
Dr. John Kincaid, a neurologist specializing in CMT at Indiana University School of Medicine, explains that while some nerve damage can cause pain or loss of sensation, these symptoms are usually secondary to muscle weakness, which is the primary issue for most patients.
Despite these challenges, Jackson remains committed to his music and his fans. “I want to give [fans] the best show I can,” he said, emphasizing his dedication to making this farewell tour a memorable experience for all.
The “Last Call: One More for the Road” tour marks the end of an era for Alan Jackson and his fans. It is a testament to his resilience and passion for performing, even in the face of a debilitating condition.
—
Photo Credit: Tony Norkus / Shutterstock.com